uniQure Receives FDA Fast Track Designation for AMT-130

AMT-130 gene therapy consistes of a recombinant AAV5 vector carrying a DNA cassette encoding a microRNA that non-selectively lowers or knocks-down...

BioNtech swallows MAB Discovery antibody unit

Under the terms of the agreement, BioNTech will acquire all assets, employees and proprietary know-how for mAb generation from MAB Discovery....

Bio-plastics production grows to 7.5 million tonnes

Production of bio-based polymers will continue to grow at the same rate as petrochemical polymers and plastics resulting in a market share of...

AMR network CARB-X expands reach

Launched in the US by BARDA in 2016, CARB-X has a budget of US$450m from 2017 till 2021 for antibacterial R&D, particularly for investments...

UK launches new payment model for antimicrobials

A 5-year plan to tackle antimicrobial resistance (AMR) published by the UK government has ambitious goals. Using electronic prescription, it aims at...

Novozymes partners with Carbios subsidiary Carbiolice

Under the terms the agreement, Novozymes, the world's largest enzyme supplier, will upscale and produce Carbios' patented...

EMA recommends bluebird's β-thalassemia gene therapy

Patients suffering from beta-thalassaemia cannot produce enough beta-globin, a key component of haemoglobin, the protein that carries the oxygen in...